<DOC>
	<DOCNO>NCT00753753</DOCNO>
	<brief_summary>The purpose study determine effect clopidogrel aspirin reactivity measure point-of-care platelet function assay thrombotic bleeding event percutaneous coronary intervention ( PCI ) drug elute bare metal stent . Methods : Platelet reactivity clopidogrel aspirin therapy measure PCI VerifyNow ( Accumetrics Inc. , San Diego , CA , USA ) P2Y12 aspirin assay respectively 1000 consecutive patient 20 center France undergo coronary angioplasty stent . Exclusion criterion : Acute myocardial infarction , treatment vitamin K antagonists use antiGP2b3a PCI . All patient pre-treated clopidogrel aspirin . Non-response aspirin clopidogrel determine accord result VerifyNow assay ( cut : &lt; 15 % P2Y12 &gt; 550 ARU aspirin ) . The primary end point occurrence definite probable stent thrombosis ( ARC definition ) secondary end-points include global cardio-vascular mortality , non fatal myocardial infarction major bleeding . A clinical evaluation schedule discharge telephone contact one month one year .</brief_summary>
	<brief_title>VerifyNow French Registry</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Coronary angioplasty stent Use AGP2b3a Acute myocardial infarction No aspirin clopidogrel pretreatment Use AVK Aspirin clopidogrel contreindication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>stent thrombosis</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>aspirin</keyword>
	<keyword>bleeding</keyword>
	<keyword>coronary</keyword>
	<keyword>angioplasty</keyword>
</DOC>